期刊文献+

新型肿瘤分子标志物循环微小RNA的研究进展 被引量:4

Research progress of circulating microRNA as a new biomarker of cancer
原文传递
导出
摘要 肿瘤作为威胁人类健康的最主要疾病之一,早期诊断、个体化治疗方案的选择及复发的判断对于预后有重要意义.微小RNA(miRNA)是一类具有调节作用的小片段RNA分子,近几年逐渐成为研究热点.miRNA分子在体液及循环系统中稳定存在,而且某些miRNA在肿瘤患者中特异性表达,对肿瘤的诊断及预后具有指导意义.文章综述有关循环miRNA的研究报道,探讨循环miRNA作为新型肿瘤分子标志物的意义及其局限性. Cancer is one of the most dangerous diseases that threaten human health.The early diagnosis individual treatment and accurate judgement of recurrence play important roles in prognosis.microRNA (miRNA) is a class of small fragments of RNA molecules which has the ability to regulate the gene expression.In recent years,some researchers have begun to focus on it.Studies have shown that the great stability of circulating miRNA in body fluid,as well as the specificity in many types of cancer,which may be important for the diagnosis and prognosis of cancer patients.In this review,the advantages and limitations of circulating miRNA as a new biomarker of cancer are birfly summarized.
出处 《肿瘤研究与临床》 CAS 2013年第10期708-710,共3页 Cancer Research and Clinic
关键词 循环微小RNA 肿瘤 诊断 预后 分子标记物 Circulating microRNA Neoplasms Diagnosis Prognosis Biological marker
  • 相关文献

参考文献4

二级参考文献38

  • 1Ying Zeng, Nan-Nan Liu, Guang-Hui Dong, Jie Chen, Bin Wang,Qing-Min Sun, Li Yang.Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population[J].World Journal of Gastroenterology,2010,16(28):3578-3583. 被引量:14
  • 2白世平,罗绪刚,吕林.线粒体在细胞凋亡中的介导作用[J].生命科学,2006,18(4):368-372. 被引量:7
  • 3Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 4Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 5Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 6Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 7Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 8Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 9Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 10Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.

共引文献1074

同被引文献45

  • 1Lopez-Serra P, Esteller M. DNA methylation associated silencing of tumor-suppressor microRNAs in cancer [J]. Oncogene, 2012, 31: 16O9-1622.
  • 2Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144: 646-674.
  • 3Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation [J]. N Engl J Med, 2011,364: 2507-2516.
  • 4Davies MA, Samuels Y. Analysis of the genome to personalize therapy for melanoma[J]. Oncogene, 2010, 29: 5545-5555.
  • 5Carvajal RD, Antoneseu CR, Wolchok JD, et al. KIT as a therapeutic target in metastatic melanoma[J]. JAMA, 2011, 305: 2327-2334.
  • 6Blokhin E, Pulitzer M, Busam KJ. Immunohistoehemieal expression of p16 in desmoplastic melanoma[J]. J Cutan Pathol, 2013, 40: 796-800.
  • 7Paraiso KH, Xiang Y, Rebecca VW, et al. PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression[J]. Cancer Res, 2011, 71: 2750-2760.
  • 8Hertzman Johansson C, Azimi A, Frostvik Stoh M, et al. Assoeiation of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines[J]. Melanoma Res, 2013, [Epub ahead of print].
  • 9Glud M, Gniadecki R. MicroRNAs in the pathogenesis of malignant melanoma[J]. J Eur Aead Dermatol Venereol, 2013, 27: 142-150.
  • 10Mueller DW, Bosserhoff AK. The evolving concept of 'melano-miRs'- microRNAs in melanoma genesis [J]. Pigment Cell Melanoma Rcs, 2010, 23: 620-626.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部